A consensus article co-authored by researchers from the European Society for Primary Care Gastroenterology and Oxford PharmaGenesis is in the top 10 most accessed papers in a leading gastroenterology journal. The systematic-review-based consensus article breaks new ground by summarizing complex information for clinicians in primary care regarding the use of probiotics in the treatment of patients with lower gastrointestinal symptoms. The article, which first appeared online in 2013, was downloaded nearly 5000 times in 2014, placing it in the top 10 recently published papers in Alimentary Pharmacology & Therapeutics by electronic downloads. It was also placed in the top 10 most cited of all articles published in the journal in 2013–14.
The probiotics consensus paper is part of an ongoing collaboration between Oxford PharmaGenesis and Professor Pali Hungin at the School of Medicine, Pharmacy and Health at Durham University, UK. The partnership has resulted in a number of systematic-review-based articles being published in peer-reviewed journals, and has led to several members of Oxford PharmaGenesis being awarded honorary positions at Durham University.
Further reading
- Hungin AP, Mulligan C, Pot B, Whorwell P, Agréus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Rubin G, Winchester C, de Wit N, for the European Society for Primary Care Gastroenterology. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide. Aliment Pharmacol Ther 2013;38:864–86. http://dro.dur.ac.uk/13276/1/13276.pdf
- Hungin APS, Becher A, Cayley B, Heidelbaugh JJ, Muris JWM, Rubin G, Seifert B. Irritable bowel syndrome: an integrated explanatory model for clinical practice. Neurogastroenterol Motil 2015; in press.
- Hungin AP, Molloy-Bland M, Claes R, Heidelbaugh J, Cayley WE Jr, Muris J, Seifert B, Rubin G, de Wit N. Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care – a Rome Foundation Working Team Report. Aliment Pharmacol Ther 2014;40:1133–45. http://www.medscape.com/viewarticle/833441_1
- Hungin AP, Hill C, Molloy-Bland M, Raghunath A. Systematic review: patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2012;10:109–16. http://www.ncbi.nlm.nih.gov/pubmed/21782770
- Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther 2009;30:331–42. http://www.ncbi.nlm.nih.gov/pubmed/19660016
